Aptevo Therapeutics Inc (APVO)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 03-2023 | 12-2022 | 09-2022 | 06-2022 | 03-2022 | |
| Cash Flows From Operating Activities | |||||
| Net Income | 2,773 | 8,027 | 12,669 | 20,313 | -7,697 |
| Depreciation Amortization | 178 | 901 | 740 | 518 | 242 |
| Accounts payable and accrued liabilities | -909 | -394 | -1,383 | -2,245 | -798 |
| Other Working Capital | 690 | 2,144 | 3,983 | 3,788 | 50 |
| Other Operating Activity | 1,834 | -31,700 | -31,092 | -30,561 | 3,086 |
| Operating Cash Flow | $4,566 | $-21,022 | $-15,083 | $-8,187 | $-5,117 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | N/A | -29 | -29 | -25 | N/A |
| Investing Cash Flow | $N/A | $-29 | $-29 | $-25 | $N/A |
| Cash Flows From Financing Activities | |||||
| Debt Repayment | -3,467 | -12,267 | -11,767 | -11,267 | -10,767 |
| Common Stock Issued | 1,602 | 6,934 | 436 | 436 | N/A |
| Other Financing Activity | -8 | 2,717 | 2,717 | 2,717 | 5,831 |
| Financing Cash Flow | $-1,873 | $-2,616 | $-8,614 | $-8,114 | $-4,936 |
| Beginning Cash Position | 22,635 | 46,303 | 46,303 | 46,303 | 46,303 |
| End Cash Position | 25,328 | 22,636 | 22,577 | 29,977 | 36,250 |
| Net Cash Flow | $2,693 | $-23,667 | $-23,726 | $-16,326 | $-10,053 |
| Free Cash Flow | |||||
| Operating Cash Flow | 4,566 | -21,022 | -15,083 | -8,187 | -5,117 |
| Capital Expenditure | N/A | -29 | -29 | -25 | N/A |
| Free Cash Flow | 4,566 | -21,051 | -15,112 | -8,212 | -5,117 |